121 related articles for article (PubMed ID: 36271832)
1. Non-fitness status of peripheral NK cells defined by decreased NKp30 and perforin, and increased soluble B7H6, in cervical cancer patients.
Gutierrez-Silerio GY; Bueno-Topete MR; Vega-Magaña AN; Bastidas-Ramirez BE; Gutierrez-Franco J; Escarra-Senmarti M; Pedraza-Brindis EJ; Peña-Rodriguez M; Ramos-Marquez ME; Delgado-Rizo V; Banu N; Alejandre-Gonzalez AG; Fafutis-Morris M; Haramati J; Del Toro-Arreola S
Immunology; 2023 Mar; 168(3):538-553. PubMed ID: 36271832
[TBL] [Abstract][Full Text] [Related]
2. Characterization of B7H6, an endogenous ligand for the NK cell activating receptor NKp30, reveals the identity of two different soluble isoforms during normal human pregnancy.
Gutierrez-Franco J; Hernandez-Gutierrez R; Bueno-Topete MR; Haramati J; Navarro-Hernandez RE; Escarra-Senmarti M; Vega-Magaña N; Del Toro-Arreola A; Pereira-Suarez AL; Del Toro-Arreola S
Immunobiology; 2018 Jan; 223(1):57-63. PubMed ID: 29055565
[TBL] [Abstract][Full Text] [Related]
3. Altered NCR3 Splice Variants May Result in Deficient NK Cell Function in Renal Cell Carcinoma Patients.
Wang X; Huang L; Wen X; Li D; Yang G; Zheng J
In Vivo; 2024; 38(1):174-183. PubMed ID: 38148073
[TBL] [Abstract][Full Text] [Related]
4. Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors.
Delahaye NF; Rusakiewicz S; Martins I; Ménard C; Roux S; Lyonnet L; Paul P; Sarabi M; Chaput N; Semeraro M; Minard-Colin V; Poirier-Colame V; Chaba K; Flament C; Baud V; Authier H; Kerdine-Römer S; Pallardy M; Cremer I; Peaudecerf L; Rocha B; Valteau-Couanet D; Gutierrez JC; Nunès JA; Commo F; Bonvalot S; Ibrahim N; Terrier P; Opolon P; Bottino C; Moretta A; Tavernier J; Rihet P; Coindre JM; Blay JY; Isambert N; Emile JF; Vivier E; Lecesne A; Kroemer G; Zitvogel L
Nat Med; 2011 Jun; 17(6):700-7. PubMed ID: 21552268
[TBL] [Abstract][Full Text] [Related]
5. B7H6-derived peptides trigger TNF-α-dependent immunostimulatory activity of lymphocytic NK92-MI cells.
Phillips M; Romeo F; Bitsaktsis C; Sabatino D
Biopolymers; 2016 Sep; 106(5):658-72. PubMed ID: 27216712
[TBL] [Abstract][Full Text] [Related]
6. B7H6 is a functional ligand for NKp30 in rat and cattle and determines NKp30 reactivity toward human cancer cell lines.
Bjørnsen EG; Thiruchelvam-Kyle L; Hoelsbrekken SE; Henden C; Saether PC; Boysen P; Daws MR; Dissen E
Eur J Immunol; 2019 Jan; 49(1):54-65. PubMed ID: 30512185
[TBL] [Abstract][Full Text] [Related]
7. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.
Garcia-Iglesias T; Del Toro-Arreola A; Albarran-Somoza B; Del Toro-Arreola S; Sanchez-Hernandez PE; Ramirez-Dueñas MG; Balderas-Peña LM; Bravo-Cuellar A; Ortiz-Lazareno PC; Daneri-Navarro A
BMC Cancer; 2009 Jun; 9():186. PubMed ID: 19531227
[TBL] [Abstract][Full Text] [Related]
8. Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma.
Mantovani S; Oliviero B; Lombardi A; Varchetta S; Mele D; Sangiovanni A; Rossi G; Donadon M; Torzilli G; Soldani C; Porta C; Pedrazzoli P; Chiellino S; Santambrogio R; Opocher E; Maestri M; Bernuzzi S; Rossello A; Clément S; De Vito C; Rubbia-Brandt L; Negro F; Mondelli MU
Hepatology; 2019 Mar; 69(3):1165-1179. PubMed ID: 30153337
[TBL] [Abstract][Full Text] [Related]
9. NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome.
Rusakiewicz S; Nocturne G; Lazure T; Semeraro M; Flament C; Caillat-Zucman S; Sène D; Delahaye N; Vivier E; Chaba K; Poirier-Colame V; Nordmark G; Eloranta ML; Eriksson P; Theander E; Forsblad-d'Elia H; Omdal R; Wahren-Herlenius M; Jonsson R; Rönnblom L; Nititham J; Taylor KE; Lessard CJ; Sivils KL; Gottenberg JE; Criswell LA; Miceli-Richard C; Zitvogel L; Mariette X
Sci Transl Med; 2013 Jul; 5(195):195ra96. PubMed ID: 23884468
[TBL] [Abstract][Full Text] [Related]
10. Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30.
Butler SE; Brog RA; Chang CH; Sentman CL; Huang YH; Ackerman ME
Cancer Immunol Immunother; 2022 Jan; 71(1):165-176. PubMed ID: 34046711
[TBL] [Abstract][Full Text] [Related]
11. NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution.
Messaoudene M; Fregni G; Enot D; Jacquelot N; Neves E; Germaud N; Garchon HJ; Boukouaci W; Tamouza R; Chanal J; Avril MF; Toubert A; Zitvogel L; Rusakiewicz S; Caignard A
Oncoimmunology; 2016; 5(12):e1154251. PubMed ID: 28123867
[TBL] [Abstract][Full Text] [Related]
12. Development of unique cytotoxic chimeric antigen receptors based on human scFv targeting B7H6.
Hua CK; Gacerez AT; Sentman CL; Ackerman ME
Protein Eng Des Sel; 2017 Oct; 30(10):713-721. PubMed ID: 29040754
[TBL] [Abstract][Full Text] [Related]
13. Analysis of shark NCR3 family genes reveals primordial features of vertebrate NKp30.
Kinlein A; Janes ME; Kincer J; Almeida T; Matz H; Sui J; Criscitiello MF; Flajnik MF; Ohta Y
Immunogenetics; 2021 Aug; 73(4):333-348. PubMed ID: 33742259
[TBL] [Abstract][Full Text] [Related]
14. Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
Queiroz GAN; Mascarenhas REM; Vieillard V; Andrade RL; Galvão-Castro B; Grassi MFR
BMC Infect Dis; 2019 May; 19(1):433. PubMed ID: 31101076
[TBL] [Abstract][Full Text] [Related]
15. The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance.
Kilian M; Friedrich MJ; Lu KH; Vonhören D; Jansky S; Michel J; Keib A; Stange S; Hackert N; Kehl N; Hahn M; Habel A; Jung S; Jähne K; Sahm F; Betge J; Cerwenka A; Westermann F; Dreger P; Raab MS; Meindl-Beinker NM; Ebert M; Bunse L; Müller-Tidow C; Schmitt M; Platten M
Sci Immunol; 2024 May; 9(95):eadj7970. PubMed ID: 38701193
[TBL] [Abstract][Full Text] [Related]
16. Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort.
Prada N; Antoni G; Commo F; Rusakiewicz S; Semeraro M; Boufassa F; Lambotte O; Meyer L; Gougeon ML; Zitvogel L
Oncoimmunology; 2013 Mar; 2(3):e23472. PubMed ID: 23802087
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC.
Flajnik MF; Tlapakova T; Criscitiello MF; Krylov V; Ohta Y
Immunogenetics; 2012 Aug; 64(8):571-90. PubMed ID: 22488247
[TBL] [Abstract][Full Text] [Related]
18. NKp30 isoforms in patients with chronic hepatitis C virus infection.
Mantovani S; Mele D; Oliviero B; Barbarini G; Varchetta S; Mondelli MU
Immunology; 2015 Oct; 146(2):234-42. PubMed ID: 26094914
[TBL] [Abstract][Full Text] [Related]
19. Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.
Golden-Mason L; Cox AL; Randall JA; Cheng L; Rosen HR
Hepatology; 2010 Nov; 52(5):1581-9. PubMed ID: 20812318
[TBL] [Abstract][Full Text] [Related]
20. Coevolution of MHC genes (LMP/TAP/class Ia, NKT-class Ib, NKp30-B7H6): lessons from cold-blooded vertebrates.
Ohta Y; Flajnik MF
Immunol Rev; 2015 Sep; 267(1):6-15. PubMed ID: 26284468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
